Cytotoxicity of allitinib, an irreversible anti-EGFR agent, in a large panel of human cancer-derived cell lines: KRAS mutation status as a predictive biomarker
Crossref DOI link: https://doi.org/10.1007/s13402-016-0270-z
Published Online: 2016-02-26
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Silva-Oliveira, Renato José
Silva, Viviane Aline Oliveira
Martinho, Olga
Cruvinel-Carloni, Adriana
Melendez, Matias Eliseo
Rosa, Marcela Nunes
de Paula, Flávia Escremim
de Souza Viana, Luciano
Carvalho, André Lopes
Reis, Rui Manuel
Text and Data Mining valid from 2016-02-26